Verify that the patient is receiving some source of exogenous glucose before initiating infusion (e.g., total parenteral nutrition [TPN], i.v. fluids containing dextrose, or enteral nutrition ...

Upon cessation of glucose infusion, the drop in plasma glucose was less pronounced with NNC2215 compared with insulin degludec, demonstrating the glucose-sensitive switching of NNC2215 and ...

[18] In a retrospective study conducted by Rosmarin et al., [19] 48.6% of subjects who received TPN dextrose infusion at rates of >5 mg/ kg/min exhibited hyperglycemia, whereas none of the ...